Showing 881 - 900 results of 2,687 for search '"chemotherapy"', query time: 0.06s Refine Results
  1. 881

    Safety of Pegfilgrastim (Neulasta) in Patients with Sickle Cell Trait/Anemia by Pashtoon Murtaza Kasi, Mrinal M. Patnaik, Prema P. Peethambaram

    Published 2013-01-01
    “…Pegfilgrastim (Neulasta) is a recombinant filgrastim (human granulocyte colony-stimulating factor (G-CSF)) attached to a polyethylene glycol (PEG) molecule and is given as part of chemotherapy regimens that are associated with significant myelosuppression and risk for febrile neutropenia. …”
    Get full text
    Article
  2. 882

    Angiosarcoma Arising in a Patient with a 10-Year-Old Hemangioma by Michael J. Nathenson, Diana Molavi, Albert Aboulafia

    Published 2014-01-01
    “…She declined systemic adjuvant chemotherapy after a thorough discussion about the risks and benefits of chemotherapy, and she currently remains disease free one year after the surgery.…”
    Get full text
    Article
  3. 883

    Obstructive shock secondary to an unusual cause: primary cardiac lymphoma by Gregoire Ottavy, Laurent Camous, Claire Fieschi, Lucas Della Torre, Jean-David Pommier

    Published 2025-01-01
    “…Conclusion When a cardiac mass is associated with extracardiac symptoms indicative of a hematological malignancy, the preferred treatment is chemotherapy, and cardiac surgery should be avoided.…”
    Get full text
    Article
  4. 884

    The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer by Ranjeeta Thapa, George D. Wilson

    Published 2016-01-01
    “…Research to date suggests use of monoclonal antibodies against different CD44 variant isoforms and targeted inhibition of HA/CD44-mediated signaling combined with conventional radio/chemotherapy may be the most favorable therapeutic strategy for future treatments of advanced stage malignancies. …”
    Get full text
    Article
  5. 885

    Endovascular Treatment of Vertebral Column Metastases Using Intra-Arterial Cisplatin: Pilot Experience by Bohdan W. Chopko

    Published 2014-01-01
    “…Treatment of spinal column metastatic tumors is challenging, especially in the setting of progressive disease despite previous radiation and chemotherapy. Intra-arterial chemotherapy is an uncommonly used but established treatment for head and neck cancers, retinoblastoma, and glioblastoma. …”
    Get full text
    Article
  6. 886

    Bilateral Breast Masses with a Rare Etiology by Friederike Thieringer, Gideon Sartorius, Katrin Kalf, Viola Heinzelmann, Marcus Vetter

    Published 2013-01-01
    “…Six months after finishing chemotherapy the patient remained in complete remission. …”
    Get full text
    Article
  7. 887

    Acute Progressive Visual Loss in a Case of Acute Myeloid Leukemia: Challenges in the Utility of Molecular Tests in Early Diagnose of Cytomegalovirus Retinitis by Ali Amanati, Nader Shakibazad, Bahman Pourabbas, Mohammad Hossein Nowroozzadeh, Soheila Zareifar, Omid Reza Zekavat

    Published 2018-01-01
    “…Viral infections, especially cytomegalovirus infection, may present with vague clinical pictures during any time of chemotherapy, which may not be easily distinguishable from bacterial or fungal retinitis and also chemotherapy-induced retinopathies. …”
    Get full text
    Article
  8. 888

    Perioperative Radiotherapy in the Management of Rectal Cancer by Lars Påhlman

    Published 2001-01-01
    “…However, when postoperative irradiation has been combined with chemotherapy, a survival benefit has been demonstrated. …”
    Get full text
    Article
  9. 889

    An Atypical Presentation of Sporadic Jejunal Burkitt’s Lymphoma by Pratik Naik, James Wang, Michael J. Brazeau, Domingo Rosario

    Published 2016-01-01
    “…Treatment consisted of bowel resection prior to chemotherapy due to concern for perforation with chemotherapy. …”
    Get full text
    Article
  10. 890

    Changing Management of Clinical Low-Stage Testicular Cancer by Timothy Gilligan

    Published 2005-01-01
    “…The management of clinical stage I testicular GCTs has grown more complicated due to the emergence of a brief course of chemotherapy as an additional treatment option for stage I seminomas and stage I nonseminomas. …”
    Get full text
    Article
  11. 891

    Delayed Migration of a WallFlex Enteral Stent Resulting in Jejunal Perforation by Phillip S. Ge, Rabindra R. Watson, David C. Chen, V. Raman Muthusamy

    Published 2013-01-01
    “…Four months later, while actively undergoing chemotherapy, he developed acute abdominal pain and was found to have delayed stent migration and jejunal perforation. …”
    Get full text
    Article
  12. 892

    Metastases to the Thyroid Presenting as a Metabolically Inactive Incidental Thyroid Nodule with Stable Size in 15 Months by Subhashini Yaturu, Raina A. Patel

    Published 2014-01-01
    “…A 63-year-old male with history of adenocarcinoma of the right lobe lung (5 years prior to presentation), treated with surgery and chemotherapy, followed by new adenosquamous lung cancer in the left lobe of the lung (one year prior to presentation), treated surgically followed by adjuvant chemotherapy, was referred to Endocrinology section for evaluation of an incidental thyroid nodule on CT chest. …”
    Get full text
    Article
  13. 893

    Anti-Toxoplasma Effects of Dracocephalum Polychaetum Essential Oil by Faham Khamesipour, Amirhossein Pourmohammad, Mohsen Jafarian-Dehkordi

    Published 2022-01-01
    “…Toxoplasma gondii is a common parasitic disease with a cosmopolitan prevalence, causing severe health problems. Although chemotherapy for toxoplasmosis is readily available, most have side effects. …”
    Get full text
    Article
  14. 894

    Growing Teratoma Syndrome by Anna Scavuzzo, Zael Arturo Santana Ríos, Nancy Reynoso Noverón, Miguel Angel Jimenez Ríos

    Published 2014-01-01
    “…Growing teratoma syndrome (GTS) is a rare clinical entity, which presents with enlarging teratomas masses of the retroperitoneum or other locations, occurring during or after systemic chemotherapy for the treatment of nonseminomatous germ cell of the testis (NSGCT), with normalised tumour markers. …”
    Get full text
    Article
  15. 895

    Comparison of Cantharidin Toxicity in Breast Cancer Cells to Two Common Chemotherapeutics by Katie M. Kern, Jennifer R. Schroeder

    Published 2014-01-01
    “…As part of a larger study synthesizing a more directed form of chemotherapy, we have begun to assess the efficacy of different potential toxins that could be delivered locally rather than systemically. …”
    Get full text
    Article
  16. 896

    Cerebral Sinus Venous Thrombosis due to Asparaginase Therapy by Youssef Alsaid, Shamshad Gulab, Mohammed Bayoumi, Saleh Baeesa

    Published 2013-01-01
    “…At one-year followup, he had complete response to chemotherapy for ALL, with residual mild left hemiparesis, and his MRI scans revealed recanalized venous sinuses. …”
    Get full text
    Article
  17. 897

    Primary ovarian peripheral primitive neuroectodermal tumor presented with breast metastasis; Case report by Razan Rabi, Majd Hamed Allah, Yusuf Dawabsheh

    Published 2025-01-01
    “…Despite treatment with radiotherapy and two cycles of high-dose Ifosfamide chemotherapy, her condition deteriorated, and she passed away in April 2024. …”
    Get full text
    Article
  18. 898

    Acute Cardiogenic Shock Induced by Infusional 5-Fluorouracil by Jeffrey Sulpher, Franco Dattilo, Susan Dent, Michele Turek, M. Neil Reaume, Christopher Johnson

    Published 2014-01-01
    “…A follow-up echocardiogram performed 5 days after initial presentation revealed an ejection fraction of 59 percent, with no evidence of wall motion abnormalities. Subsequent 5-FU chemotherapy was discontinued, and the patient went on to receive second-line chemotherapy.…”
    Get full text
    Article
  19. 899

    A Canadian Perspective on Systemic Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma by Anna Spreafico, Eric Winquist, Cheryl Ho, Brian O’Sullivan, Nathaniel Bouganim, Neil Chua, Sarah Doucette, Lillian L. Siu, Desiree Hao

    Published 2025-01-01
    “…The addition of anti-PD-1 monoclonal antibodies to chemotherapy has been shown to extend progression-free survival in recurrent r/m NPC compared to chemotherapy alone; however, approval of PD-1 inhibitors in Canada has lagged behind other jurisdictions where NPC is non-endemic. …”
    Get full text
    Article
  20. 900

    Real‐World Prevalence, Treatment Patterns, and Outcomes for Patients With HER2 (ERBB2)‐Mutant Metastatic Non‐Small Cell Lung Cancer, From a US‐Based Clinico‐Genomic Database... by Sarah Waliany, Misako Nagasaka, Leah Park, Clara Lam, Zoe Jiang, Feng Lin, Joel W. Neal

    Published 2024-12-01
    “…Results Among 9206 patients with mNSCLC, 164 (1.78%) met the eligibility criteria (mean age: 67.3 years, 63.4% White, 56.7% female, and 53.0% with a smoking history). 132/164 (80.5%) had at least one line of treatment. Platinum‐based chemotherapy (45.5%) and immune checkpoint inhibitor (ICI) with chemotherapy (28.0%) were the most frequently used first‐line treatments. …”
    Get full text
    Article